Defining a High-Quality Myalgic Encephalomyelitis/Chronic Fatigue Syndrome cohort in UK Biobank
Gemma L. Samms,
No information about this author
Chris P. Ponting
No information about this author
NIHR Open Research,
Journal Year:
2025,
Volume and Issue:
5, P. 39 - 39
Published: April 28, 2025
Background
Progress
in
Myalgic
Encephalomyelitis/Chronic
Fatigue
Syndrome
(ME/CFS)
research
is
being
slowed
by
the
relatively
small-scale
studies
performed
whose
results
are
often
not
replicated.
could
be
accelerated
analyses
of
large
population-scale
projects,
such
as
UK
Biobank
(UKB),
which
provide
extensive
phenotype
and
genotype
data
linked
to
both
ME/CFS
cases
controls.
Methods
Here,
we
analysed
overlap
discordance
among
four
UKB-defined
cohorts,
additional
questionnaire
when
available.
Results
A
total
5,354
UKB
individuals
were
at
least
one
piece
evidence
MECFS,
a
higher
proportion
(1.1%)
than
most
prevalence
estimates.
Only
third
(36%;
n=1,922)
had
2
or
more
pieces
for
part
due
missingness.
For
same
participant,
status
defined
ICD-10
(International
Classification
Diseases,
Tenth
Revision)
code
G93.3
(Post-viral
fatigue
syndrome)
was
likely
supported
another
type
(72%);
Pain
Questionnaire
responses
(43%),
Conclusions
We
conclude
that
UKB,
potentially
other
biobanks,
best
multiple,
single,
lines
evidence.
Finally,
raise
estimated
410,000
using
consistent
status,
accounting
those
who
no
opportunity
participate
bed-
house-bound.
Language: Английский